NewGen Pharma

NewGen Pharma is a specialty pharmaceutical company focused on improving access to innovative and hard-to-source medicines, particularly for patients with rare, complex, and life-threatening diseases. The company appears to operate primarily as a commercial access, licensing, and supply organization rather than a drug discovery biotech, with emphasis on orphan drugs, named-patient supply, and partnerships with original and generic manufacturers. Its website highlights activities in rare disease, oncology, immunology, and neuroscience, and notes that it is an authorized supplier under Turkey's Named Patient Program. NewGen Pharma is headquartered in Istanbul and positions itself as a bridge between global therapy developers and patients facing access barriers in Turkey and nearby markets.